FDA.reportPublic FDA data

histrelin acetate 0.00271 MG/HR Drug Implant

RxCUI
1740437
RxNorm name
histrelin acetate 0.00271 MG/HR Drug Implant
Display name
histrelin acetate 0.00271 MG/HR Drug Implant
Full name
histrelin acetate 0.00271 MG/HR Drug Implant
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SUPPRELIN LAHISTRELIN ACETATEEndo USA, Inc.d8fb000e-3cc9-4803-b71d-2cc5976619772025-09-25Warnings, Adverse reactionsExact identifier
rxcui: 1740437

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
d8fb000e-3cc9-4803-b71d-2cc597661977histrelin acetate 50 MG (65 MCG per 24HR) Subcutaneous Drug Implant [PSN] · histrelin acetate 0.00271 MG/HR Drug Implant [SCD] · histrelin acetate 50 MG (65 MCG per 24 HR) Drug Implant [SY]338These highlights do not include all the information needed to use SUPPRELIN ® LA safely and effectively. See full prescribing information for SUPPRELIN ® LA. SUPPRELIN LA (histrelin acetate) subcutaneous implant Initial U.S. Approval: 199120250925